AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.
In a groundbreaking development, UCLA researchers from the Jonsson Comprehensive Cancer Center have unveiled an innovative artificial intelligence AI model. This model centred on epigenetic factors, demonstrates unparalleled success in predicting patient outcomes across cancer types.
Zisis Kozlakidis and Caboux Elodie from the International Agency for Research on Cancer discuss how the COVID-19 pandemic accelerated the adoption of changes in public health interventions and patient care.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
October is dedicated to raising awareness for breast cancer. A recent study highlights the need for more education into the less common symptoms of breast cancer.
A recent study unveils alarming findings about women's cancer risk, indicating significant connections between the disease and exposure to certain endocrine-disrupting chemicals.
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Innovation for new healthcare technology has been funded toward treatments for Alzheimer’s, cancer and more, with support going to digital hubs and technology-assisted surgery.
